Conference Calls & Webcasts

Latest Webcast

04/29/2014 - Conference Call: Q1 2014 Results

MorphoSys AG will publish its first three months' 2014 results on April 29, 2014.

At 2:00 pm CEST (1:00 pm BST, 8:00 am EDT), the Management Board of MorphoSys AG will host a public conference call to present MorphoSys’s financial results for the first three months of 2014 and provide further details on the Company’s latest developments.

Dial-in numbers (listen only):
Germany:  +49 89 2444 32975
United Kingdom:  +44 20 3003 2666
USA: +1 202 204 1514

An audio replay and manuscripts of the conference will be available in due course.

Archive

06/27/2013 - Conference Call and Webcast: Strategic Alliance with Celgene on MOR202

On June 26, 2013 MorphoSys and Celgene Corporation announced an agreement to jointly develop MOR202 globally and to co-promote MOR202 in Europe.

Press Release

MorphoSys held a public conference call and webcast on Thursday, June 27, 2013 to present more information on the transaction.

Replay of Webcast

06/06/2013 - Webcast: Jefferies 2013 Global Healthcare Conference, New York, USA

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the Jefferies 2013 Global Healthcare Conference in New York, USA, on June 6, 2013.

Go to Webcast...

06/03/2013 - Conference Call: MorphoSys Signs Global License Agreement with GlaxoSmithKline for MOR103 Program

On June 3 2013, MorphoSys announced that they have entered into a global agreement with GlaxoSmithKline (GSK) to develop and commercialize MOR103.

MorphoSys held a public conference call to present more information on the agreement.

05/03/2013 - Conference Call and Webcast: Q1 2013 Results

MorphoSys AG published its first three months’ 2013 results on May 3, 2013.

During a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first three months of 2013 and provided further details on the Company’s latest developments.

Replay of the Q1 2013 Webcast

03/14/2013 - Barclays Global Healthcare Conference 2013

Jens Holstein, CFO of MorphoSys AG, presented the Company at the Barclays Global Healthcare Conference in Miami, FL, USA, on Thursday, March 14, 2013.

Go to Webcast...

03/05/2013 - Year End 2012 and Q4 Results

MorphoSys published its Annual Financial Results 2012 on March 5, 2013. In conjunction with that, the Company held a conference call to further discuss the financial and operational results.

Go to Replay of Webcast

01/10/2013 - Webcast: J.P. Morgan Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the J.P. Morgan Healthcare Conference in San Francisco, USA, on Thursday, January 10, 2013.

 Go to Webcast...

Conference Call and Webcast: Bio-Rad plans Acquisition of MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec

On December 17, 2012 the Management Board of MorphoSys AG hosted a public conference call and webcast to present information on Bio-Rad’s planned Acquisition of MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec.

11/15/2012 - Webcast: Jefferies Global Healthcare Conference

Jens Holstein, CFO of MorphoSys AG, will present the Company at the Jefferies Global Healthcare Conference in London, UK, on November 15, 2012 at 2:20 pm GMT (9:20 am EST, 3:20 pm CET).

 Go to Webcast...

 

11/07/2012 - Conference Call and Webcast: Q3 2012 Results

MorphoSys AG published its first nine months’ 2012 results on November 7, 2012.

During a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first nine months of 2012 and provided further details on the Company’s latest developments.